Rare diseases
Investigational molecules
Locations
Back to Germany32 clinical trials in Sankt Augustin, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
GermanyA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
GermanyA study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.
GermanyStudy of abatacept, tocilizumab, and tofacitinib compared to a second TNF inhibitor for children with juvenile idiopathic arthritis who did not respond to TNF inhibitor treatment
GermanyA Study of MAS825 in Children and Adults with Still's Disease to Test How Well It Works and How Safe It Is
GermanyStudy of Sarilumab for Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA)
GermanyStudy on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination
GermanyGermanyStudy of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine
GermanyStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
GermanyStudy of apremilast compared to placebo in children aged 5-17 years with juvenile psoriatic arthritis
GermanyStudy on the Effects of Risankizumab and Adalimumab in Children with Active Juvenile Psoriatic Arthritis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for juvenile arthritis conditions, including studies of medications like baricitinib, ustekinumab, and bimekizumab for various forms of JIA.
Research aims to evaluate drug efficacy and safety in pediatric populations with autoimmune conditions.
Comprehensive studies on childhood cancers, with particular focus on leukemia and lymphoma treatments, including novel therapeutic approaches and combination therapies.
Investigations include targeted therapies and personalized treatment protocols for various cancer stages.
Specialized research into brain and nervous system tumors, focusing on ependymoma and medulloblastoma treatment strategies.
Studies evaluate surgical outcomes, radiation therapy approaches, and chemotherapy effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
